BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21968673)

  • 1. Metallic taste as a side effect of topical fluorouracil use.
    Han SY; Youker S
    J Drugs Dermatol; 2011 Oct; 10(10):1201-3. PubMed ID: 21968673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of superficial ulcerative squamous cell carcinoma in three horses with topical 5-fluorouracil.
    Paterson S
    Vet Rec; 1997 Dec; 141(24):626-8. PubMed ID: 9447676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six patients with early-stage cutaneous T-cell lymphoma successfully treated with topical 5-fluorouracil.
    Kannangara AP; Levitan D; Fleischer AB
    J Drugs Dermatol; 2010 Aug; 9(8):1017-8. PubMed ID: 20684155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.
    Morton C; Horn M; Leman J; Tack B; Bedane C; Tjioe M; Ibbotson S; Khemis A; Wolf P
    Arch Dermatol; 2006 Jun; 142(6):729-35. PubMed ID: 16785375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Use of 5 fluorouracil in the topical therapy of skin cancer: a review of 157 patients.
    Litwin MS; Ryan RF; Ichinose H; Reed RR; Kremetz ET
    Proc Natl Cancer Conf; 1972; 7():549-61. PubMed ID: 4764922
    [No Abstract]   [Full Text] [Related]  

  • 6. Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study.
    Hsu SH; Gan SD; Nguyen BT; Konnikov N; Liang CA
    Dermatol Surg; 2016 Sep; 42(9):1050-3. PubMed ID: 27359199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 5-fluorouracil in the management of extensive anal Bowen's disease: a preferred approach.
    Graham BD; Jetmore AB; Foote JE; Arnold LK
    Dis Colon Rectum; 2005 Mar; 48(3):444-50. PubMed ID: 15747068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reticulate Hyperpigmentation secondary to 5-fluorouracil and idarubicin.
    Jogi R; Garman M; Pielop J; Orengo I; Hsu S
    J Drugs Dermatol; 2005; 4(5):652-6. PubMed ID: 16167426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of an adverse reaction to topical 5-fluorouracil in irradiated skin.
    Lambert T; Mullinax K; Smith J
    J Drugs Dermatol; 2006 Mar; 5(3):282-3. PubMed ID: 16573264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers.
    Mansell PW; Litwin MS; Ichinose H; Krementz ET
    Cancer Res; 1975 May; 35(5):1288-94. PubMed ID: 1120313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical and systemic chemotherapy with 5-fluouracil in facial carcinoma secondary to xeroderma pigmentosum].
    Khader A; Gritli S; Boussen I; Oueslati Z; Ferjaoui M; Nouira R; Ladgham A; Boussen H
    Tunis Med; 2005 Nov; 83(11):672-4. PubMed ID: 16422364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ.
    Queen D; Trager MH; Fan W; Gordon ER; Samie FH
    Arch Dermatol Res; 2024 May; 316(6):220. PubMed ID: 38787403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
    Couch SM; Custer PL
    Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical chemotherapy of basal and squamous skin cancers with 5-fluorouracil cream.
    Litwin MS; Krementz ET
    Panminerva Med; 1974 Mar; 16(3):84-5. PubMed ID: 4449647
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic effect of topical 5-fluorouracil in conjunctival squamous carcinoma is associated with changes in matrix metalloproteinases and tissue inhibitor of metalloproteinases expression.
    Iovieno A; Lambiase A; Moretti C; Perrella E; Bonini S
    Cornea; 2009 Aug; 28(7):821-4. PubMed ID: 19574900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible findings of restricted diffusion in 5-fluorouracil neurotoxicity.
    Lucato LT; McKinney AM; Short J; Teksam M; Truwit CL
    Australas Radiol; 2006 Aug; 50(4):364-8. PubMed ID: 16884425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival intraepithelial neoplasia.
    Snyder ME
    Ophthalmology; 2003 Jul; 110(7):1289. PubMed ID: 12867379
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
    Ondo AL; Mings SM; Pestak RM; Shanler SD
    J Am Acad Dermatol; 2006 Dec; 55(6):1092-4. PubMed ID: 17097406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic results of 5-fluorouracil in multiple and unresectable facial carcinoma secondary to xeroderma pigmentosum].
    Boussen H; Zwik J; Mili-Boussen I; Rammeh N; Bouaouina N; Gritli S; el May A; Kammoun MR; Ouertani A; Ladgham A
    Therapie; 2001; 56(6):751-4. PubMed ID: 11878102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic toxicity from occlusive therapy with topical 5-fluorouracil: a case report and review of the literature.
    Sargen M; Wanat KA; Jambusaria A; Rosenbach M; Sobanko J; Miller CJ
    Dermatol Surg; 2012 Oct; 38(10):1756-9. PubMed ID: 22805044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.